stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
32.33 | 89.52 | 84.72 | 67.96 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.50) | (2.64) | (2.67) | (3.32) | |
P/B ratio |
0.19 | 0.35 | 0.42 | 0.45 | |
Price to Tangible BV |
0.21 | 0.38 | 0.45 | 0.49 | |
EV/Sales |
(123.47) | (151.91) | (107.19) | (73.77) | |
EV/EBITDA |
1.37 | 1.42 | 0.95 | 0.77 | |
EV/Operating CF |
1.30 | 1.62 | 1.11 | 0.81 | |
EV/FCF |
1.27 | 1.58 | 1.09 | 0.79 | |
Quick Ratio |
14.42 | 19.34 | 15.76 | 13.84 | |
Current Ratio |
14.81 | 19.65 | 16.20 | 14.17 | |
Net Debt/EBITDA |
6.23 | 6.50 | 5.75 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.01 | 0.00 | 0.01 | 0.01 | |
Operating CF/Net income |
0.86 | 0.93 | 0.97 | 0.77 | |
Capex/Depreciation |
(0.68) | (0.81) | (0.70) | 0.00 | |
Research and Development Expense of Revenue |
1,422.16% | 1,494.79% | 1,178.97% | 1,101.33% | |
Selling, General and Administrative Expense of Revenue |
9,360.54% | 12,679.15% | 10,360.71% | 7,107.24% | |
Intangible Assets out of Total Assets |
0.09 | 0.06 | 0.07 | 0.08 | |
Share Based Compensation of Revenue |
23.78% | 22.27% | 405.16% | 1,259.36% | |
Graham Net Nets |
4.72 | 2.64 | 2.22 | 2.02 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(381.30%) | (292.35%) | (275.34%) | (246.46%) | |
Free Cash Flow Yield |
(301.29%) | (107.33%) | (116.50%) | (136.78%) | |
Revenue per Share |
0.03 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(3.06) | (1.24) | (1.08) | (0.73) | |
Capex per Share |
(0.08) | (0.02) | (0.02) | (0.03) | |
Free Cash Flow per Share |
(3.14) | (1.26) | (1.10) | (0.75) | |
Cash per Share |
22.63 | 8.93 | 6.62 | 5.11 | |
Shareholders Equity per Share |
24.13 | 9.23 | 6.91 | 5.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
24.13 | 9.23 | 6.91 | 5.33 | |
Free Cash Flow |
(1.67) | (2.69) | (2.70) | (2.09) | |
Working Capital |
11.56 | 18.39 | 15.76 | 13.55 | |
Capital Expenditures |
(0.04) | (0.05) | (0.04) | (0.07) | |
Net Current Asset Value |
11.56 | 18.39 | 15.76 | 13.55 | |
EV/EBIT |
1.33 | 1.38 | 0.92 | 0.68 | |
Capex to Sales |
2.24 | 2.34 | 1.71 | 2.16 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.02 | 0.03 | 0.02 | 0.03 | |
Average Payables |
0.43 | 0.55 | 0.49 | 0.26 | |
Average Assets |
7.90 | 18.56 | 16.40 | 14.52 | |
Average Common Equity |
6.90 | 17.72 | 15.60 | 13.65 |
Columns are period end dates · fundamentals updated 5 Nov 2026